Xerostomia: Clinical Aspects and Treatment
Tóm tắt
Xerostomia or dry mouth is a condition that is frequently encountered in dental practice. The most common cause is the use of certain systemic medications, which make the elderly at greater risk because they are usually more medicated. Other causes include high doses of radiation and certain diseases such as SjöUgren's syndrome. Xerostomia is associated with difficulties in chewing, swallowing, tasting or speaking. This results in poor diet, malnutrition and decreased social interaction. Xerostomia can cause oral discomfort, especially for denture wearers. Patients are at increased risk of developing dental caries. A thorough intra‐oral and extra‐oral clinical examination is important for diagnosis. Treatment may include the use of salivary substitutes (Biotene), salivary stimulants such as pilocarpine, ongoing dental care, caries prevention, a review of the current prescription drug regimen and possible elimination of drugs having anticholinergic effects. Because of the ageing population, and the concomitant increase in medicated individuals, dentists can expect to be presented with xerostomia in an increasing number of patients in the coming years and therefore should be familiar with its diagnosis and treatment. Therefore, the purpose of this review is to outline for clinicians the common aetiologies, clinical identification, and routine therapeutic modalities available for individuals with xerostomia.
Từ khóa
Tài liệu tham khảo
Rhodus N L, 1990, The association of xerostomia and inadequate intake in older adults, J Am Diet Assoc, 90, 1688, 10.1016/S0002-8223(21)01876-9
Iwamoto R R., 1996, A nursing perspective on radiation‐induced xerostomia, Oncology, 12
Provenza D V, Oral Histology, 1964
Carranza F A, 2002, Carranza's Clinical Periodontology
Hochberg M C, 1998, Prevalence of symptoms of dry mouth and their relationship to saliva production in community dwelling elderly: the SEE project. Salisbury Eye Evaluation, J Rheumatol, 25, 486
Thomson W M, 1993, Medication and perception of dry mouth in a population of institutionalized elderly people, NZ Med J, 106, 219
Ship J A, Longitudinal analysis of parotid and submandibular salivary flow rates in healthy, different aged adults, J Gerontol Med Sci, 1995, M285
Ship J A, 2003, Xerostomia and the geriatric patient, J Am Geriatr Soc, 50, 535, 10.1046/j.1532-5415.2002.50123.x
Daniels T E, 2000, Xerostomia ‐ clinical evaluation and treatment in general practice, J Can Dent Assoc, 28, 933
McDonald E, 1992, Dry mouth: Diagnosing and treating its multiple causes, Geriatrics, 46, 61
Wynn R L, 2000, Artificial saliva products and drugs to treat xerostomia, Gen Dent, 48, 630
Edgar W M, 1990, Saliva and dental health
Vivino F B, 1995, Sjögren's syndrome: clinical picture and diagnostic tests, J Musculoskel Med, 12, 40
Venables P J, 1997, Viruses in the etiopathogenesis of Sjögren's syndrome, J Rheumatol, 24, 3
Royer B, 1997, Lymphomas in patients with Sjögren's syndrome and marginal zone B‐cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses, Blood, 90, 766, 10.1182/blood.V90.2.766
Greenspan B., 1996, Xerostomia: Diagnosis and Management, Oncology, 10, 7
Nagler R, 1996, Major salivary gland dysfunction in human acute and chronic graft‐versus‐host disease (GVHD), Bone Marrow Transplant, 17, 219
Tenovuo J O., 1989, Human Saliva: Clinical Chemistry and Microbiology vol 1
Jacobs C, 1996, A multicenter maintenance study of oral pilocarpine tablets for radiation‐induced xerostomia, Oncology, 10, 16
Epstein J B, 1992, The role of saliva in oral health and causes and effects of xerostomia, J Can Dent Assoc, 58, 217
Steenberghe D, 1994, Effect of a lactoperoxidase containing toothpaste in radiation‐induced xerostomia, Int Dent J, 44, 133
Banoczy J B, 1994, A clinical study with lactoperoxidase‐containing gel and toothpaste in patients with dry mouth syndrome, J Clin Dent, 5, 65
Odusola F., 1991, Chewing gum as an aid in treatment of hyposalivation, NY State Dent J, 57, 28
Fox P C, 1991, Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia), Arch Intern Med, 151, 1479
Compendium of Pharmaceuticals and Specialities (CPS).36th ed. Toronto (ON): Webcom Limited;2001.P1203.
ZuntS L.Lecture entitled: Diagnosis and management of dry mouth/xerostomia/salivary gland hypofunction.Presented at Faculty of Dentistry University of Toronto Nov. 2002.